Chemotherapy Is Virtually Useless
Wow..bet this media story slipped past the mainstream press.
It came out in 2004.
Cancer is a terrible diagnosis, no doubt about that.
But if your doctor told you the dreaded news, you would be devastated of course.
But then he would more than likely suggest to you, depending on the type of cancer , a course of chemotherapy.!
Now the doctor would only be suggesting this because he would believe it did.
Did he check..of course not..
If an inert product was suggested by a doctor that had a positive effect on the patient, we call that a placebo.
The word 'placebo' in latin for "I will please".
Great history of the word placebo Here.
The belief in the "positive" effect of chemotherapy on the patient, is a reverse placebo effect in a way.
The doctor`s belief is essentially false..as well as the patients.
Because this toxic poison has little use in helping people.!!
Chemo can shrink some tumours, but it is cytotoxic in nature and destroys the patients compromised immune system even faster than the cancer.
Just look at the facts from this Australian study.Here.
ABSTRACT:
Aims: The debate on the funding and availability of cytotoxic drugs raises questions about the contribution of curative or adjuvant
cytotoxic chemotherapy to survival in adult cancer patients.
Materials and methods: We undertook a literature search for randomised clinical trials reporting a 5-year survival benefit attributable
solely to cytotoxic chemotherapy in adult malignancies. The total number of newly diagnosed cancer patients for 22 major adult
malignancies was determined from cancer registry data in Australia and from the Surveillance Epidemiology and End Results data in the
USA for 1998. For each malignancy, the absolute number to benefit was the product of (a) the total number of persons with that
malignancy; (b) the proportion or subgroup(s) of that malignancy showing a benefit; and (c) the percentage increase in 5-year survival due
solely to cytotoxic chemotherapy. The overall contribution was the sum total of the absolute numbers showing a 5-year survival benefit
expressed as a percentage of the total number for the 22 malignancies.
Results: The overall contribution of curative and adjuvant cytotoxic chemotherapy to 5-year survival in adults was estimated to be 2.3% in
Australia and 2.1% in the USA.
Conclusion: As the 5-year relative survival rate for cancer in Australia is now over 60%, it is clear that cytotoxic chemotherapy only makes
a minor contribution to cancer survival. To justify the continued funding and availability of drugs used in cytotoxic chemotherapy,
a rigorous evaluation of the cost-effectiveness and impact on quality of life is urgently required. Morgan, G. et al. (2004). Clinical Oncology
16, 549e560
2004 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.
It came out in 2004.
Cancer is a terrible diagnosis, no doubt about that.
But if your doctor told you the dreaded news, you would be devastated of course.
But then he would more than likely suggest to you, depending on the type of cancer , a course of chemotherapy.!
Now the doctor would only be suggesting this because he would believe it did.
Did he check..of course not..
If an inert product was suggested by a doctor that had a positive effect on the patient, we call that a placebo.
The word 'placebo' in latin for "I will please".
Great history of the word placebo Here.
The belief in the "positive" effect of chemotherapy on the patient, is a reverse placebo effect in a way.
The doctor`s belief is essentially false..as well as the patients.
Because this toxic poison has little use in helping people.!!
Chemo can shrink some tumours, but it is cytotoxic in nature and destroys the patients compromised immune system even faster than the cancer.
Just look at the facts from this Australian study.Here.
ABSTRACT:
Aims: The debate on the funding and availability of cytotoxic drugs raises questions about the contribution of curative or adjuvant
cytotoxic chemotherapy to survival in adult cancer patients.
Materials and methods: We undertook a literature search for randomised clinical trials reporting a 5-year survival benefit attributable
solely to cytotoxic chemotherapy in adult malignancies. The total number of newly diagnosed cancer patients for 22 major adult
malignancies was determined from cancer registry data in Australia and from the Surveillance Epidemiology and End Results data in the
USA for 1998. For each malignancy, the absolute number to benefit was the product of (a) the total number of persons with that
malignancy; (b) the proportion or subgroup(s) of that malignancy showing a benefit; and (c) the percentage increase in 5-year survival due
solely to cytotoxic chemotherapy. The overall contribution was the sum total of the absolute numbers showing a 5-year survival benefit
expressed as a percentage of the total number for the 22 malignancies.
Results: The overall contribution of curative and adjuvant cytotoxic chemotherapy to 5-year survival in adults was estimated to be 2.3% in
Australia and 2.1% in the USA.
Conclusion: As the 5-year relative survival rate for cancer in Australia is now over 60%, it is clear that cytotoxic chemotherapy only makes
a minor contribution to cancer survival. To justify the continued funding and availability of drugs used in cytotoxic chemotherapy,
a rigorous evaluation of the cost-effectiveness and impact on quality of life is urgently required. Morgan, G. et al. (2004). Clinical Oncology
16, 549e560
2004 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.